Inter Pharma (Thailand) Market Value
| IP Stock | THB 3.50 0.04 1.16% |
| Symbol | Inter |
Inter Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Inter Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Inter Pharma.
| 11/14/2024 |
| 12/14/2024 |
If you would invest 0.00 in Inter Pharma on November 14, 2024 and sell it all today you would earn a total of 0.00 from holding Inter Pharma Public or generate 0.0% return on investment in Inter Pharma over 30 days. Inter Pharma is related to or competes with Intermedical Care, DOD Biotech, Siam Global, Dohome Public, and Mega Lifesciences. Inter Pharma Public Company Limited develops, produces, and sells healthcare products in Thailand More
Inter Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Inter Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Inter Pharma Public upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 24.26 | |||
| Value At Risk | (4.23) | |||
| Potential Upside | 3.06 |
Inter Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Inter Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Inter Pharma's standard deviation. In reality, there are many statistical measures that can use Inter Pharma historical prices to predict the future Inter Pharma's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.54) | |||
| Treynor Ratio | (0.29) |
Inter Pharma Public Backtested Returns
Inter Pharma Public holds Efficiency (Sharpe) Ratio of -0.19, which attests that the entity had a -0.19% return per unit of risk over the last 3 months. Inter Pharma Public exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Inter Pharma's Market Risk Adjusted Performance of (0.28), risk adjusted performance of (0.03), and Standard Deviation of 2.92 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.61, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Inter Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Inter Pharma is expected to be smaller as well. At this point, Inter Pharma Public has a negative expected return of -0.42%. Please make sure to check out Inter Pharma's skewness, as well as the relationship between the daily balance of power and day typical price , to decide if Inter Pharma Public performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.62 |
Good predictability
Inter Pharma Public has good predictability. Overlapping area represents the amount of predictability between Inter Pharma time series from 14th of November 2024 to 29th of November 2024 and 29th of November 2024 to 14th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Inter Pharma Public price movement. The serial correlation of 0.62 indicates that roughly 62.0% of current Inter Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.62 | |
| Spearman Rank Test | 0.75 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Inter Pharma Public lagged returns against current returns
Autocorrelation, which is Inter Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Inter Pharma's stock expected returns. We can calculate the autocorrelation of Inter Pharma returns to help us make a trade decision. For example, suppose you find that Inter Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Inter Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Inter Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Inter Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Inter Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
Inter Pharma Lagged Returns
When evaluating Inter Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Inter Pharma stock have on its future price. Inter Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Inter Pharma autocorrelation shows the relationship between Inter Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Inter Pharma Public.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Inter Stock
Inter Pharma financial ratios help investors to determine whether Inter Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Inter with respect to the benefits of owning Inter Pharma security.